We are live on !
Find out more
Keene & Associates Portfolio holdings
AUM
$125M
Turnover
12.2%
1-Year Est. Return
13.49%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$7.44M
(-5.6%)
Cap. Flow
-$3.33M
Cap. Flow % of AUM
Cap. Flow %
-2.67%
Top 10 Holdings %
Top 10 Hldgs %
34.07%
Holding
82
New
4
Increased
37
Reduced
28
Closed
6
Avg Time Held
2.2
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jacobs Solutions
J
|
+$3.09M |
| 2 |
Conagra Brands
CAG
|
+$2.46M |
| 3 |
PIMCO Ultra Short Government Active ETF
BILZ
|
+$993K |
| 4 |
Red Rock Resorts
RRR
|
+$603K |
| 5 |
CSW Industrials
CSW
|
+$583K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$4.16M |
| 2 |
Intel
INTC
|
+$2.09M |
| 3 |
Nutrien
NTR
|
+$1.09M |
| 4 |
BorgWarner
BWA
|
+$1.03M |
| 5 |
Devon Energy
DVN
|
+$977K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.72% |
| 2 | Technology | 15.13% |
| 3 | Healthcare | 14.41% |
| 4 | Industrials | 11.45% |
| 5 | Energy | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Vista Gold
VGZ
$382M
| $6.25K | 0.01% |
11,200
| – | – |
2021 Q4
12 quarters
|
|
77
DELISTED
Avanos Medical
AVNS
| – | – |
-18,165
| Closed | -$437K | – |
|
|
78
Intel
INTC
$317B
| – | – |
-89,119
| Closed | -$2.09M | – |
|
79
Lifecore Biomedical
LFCR
$243M
| – | – |
-22,410
| Closed | -$110K | – |
|
80
The Mosaic Company
MOS
$6.97B
| – | – |
-12,240
| Closed | -$328K | – |
|
81
Synaptics
SYNA
$4.69B
| – | – |
-3,255
| Closed | -$253K | – |
|
|
82
Unilever
UL
$143B
| – | – |
-56,971
| Closed | -$4.16M | – |
|
Similar funds
SSF
NBT
Keene & Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Keene & Associates held 82 positions worth $125M, down 5.6% from $132M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Keene & Associates's Q4 2024 filing shows 4 new, 37 increased, 28 reduced and 6 closed positions. Its largest new stake was Jacobs Solutions: 22,469 shares worth $2.97M. The largest sale was Unilever, an estimated $4.16M.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 19% a quarter earlier, followed by Technology and Healthcare.
- Keene & Associates's largest Q4 2024 buy was Jacobs Solutions: 22,469 shares worth $2.97M.
- Keene & Associates added most to PIMCO Ultra Short Government Active ETF in Q4 2024, an estimated $993K increase.
- Keene & Associates's biggest Q4 2024 reduction was Nutrien, cutting an estimated $1.09M.
- Keene & Associates fully exited Unilever in Q4 2024, selling an estimated $4.16M.
- Keene & Associates's ten largest holdings make up 34% of its $125M portfolio in Q4 2024.
- Keene & Associates opened 4 new positions and closed 6 in Q4 2024.
- Keene & Associates's portfolio value fell 5.6% quarter-over-quarter to $125M.
Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.